4//SEC Filing
ZUMWALT LEANNE M 4
Accession 0001562180-24-004904
CIK 0001517022other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:18 PM ET
Size
8.1 KB
Accession
0001562180-24-004904
Insider Transaction Report
Form 4
ZUMWALT LEANNE M
Director
Transactions
- Award
Common Stock
2024-06-06+30,000→ 73,700 total - Award
Stock Option (Right to buy)
2024-06-06+45,000→ 45,000 totalExercise: $1.07From: 2025-06-06Exp: 2034-06-06→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.
- [F2]The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001204946
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:18 PM ET
- Size
- 8.1 KB